Jason M. Redman - Concepedia

Author

Jason M. Redman

National Cancer Institute ORCID

Also Known As

J. Redman, J.M. Redman, Jason M Redman, Jason M. Redman, Jason Mark Redman, Jason Redman, Redman J.

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research Office of the Director ImmunityBio (United States)

About

Jason M. Redman is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	581
2	Engineering	2	2	111
3	Health Sciences	2	2	96
4	Allergy	1	1	183
5	Biology	1	1	75

Jason M. Redman

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Environmental and Antigen Receptor-Derived Signals Support Sustained Surveillance of the Lungs by Pathogen-Specific Cytotoxic T Lymphocytes Young‐Tae Lee, Jenny E Suarez-Ramirez, Tao Wu, Journal of Virology AsthmaInflammatory Lung DiseaseImmunologyImmunologic MechanismAntigen Processing	2011	183
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho, Journal for ImmunoTherapy of Cancer	2020	153
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics Danh-Tai Hoang, Gal Dinstag, Eldad D. Shulman, Nature Cancer Deep-learning FrameworkSystems BiologyEngineeringMachine LearningCancer Treatment Response	2024	100
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer Jason M. Redman, Jay Friedman, Yvette Robbins, Journal of Clinical Investigation Treg InfiltrationNeoadjuvant TherapyImmunologyPathologyImmunotherapeutics	2022	76
Abiotic and biotic stress differentially stimulate as-1 element activity in Arabidopsis Jason M. Redman, J. Whitcraft, Christopher Johnson, Plant Cell Reports BiologyPlant StressAbiotic StressBiotic StressPlant-abiotic Interaction	2002	75
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer Cem Sievers, Marco Craveiro, Jay Friedman, Cancer Cell Tumor ImmunologyNeck CancerCancer ImmunosurveillanceMedicineT-regulatory Cell	2023	65
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer Margaret E. Gatti‐Mays, Jason M. Redman, Renee N. Donahue, The Oncologist	2019	59
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) Marijo Bilušić, Sheri McMahon, Ravi A. Madan, Journal for ImmunoTherapy of Cancer	2021	59
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer Jason M. Redman, Seth M. Steinberg, James L. Gulley Journal for ImmunoTherapy of Cancer	2018	58
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules Margaret E. Gatti‐Mays, Julius Strauss, Renee N. Donahue, Clinical Cancer Research	2019	58

Page 1